» Articles » PMID: 10591218

A Telomerase Component is Defective in the Human Disease Dyskeratosis Congenita

Overview
Journal Nature
Specialty Science
Date 1999 Dec 11
PMID 10591218
Citations 479
Authors
Affiliations
Soon will be listed here.
Abstract

The X-linked form of the human disease dyskeratosis congenita (DKC) is caused by mutations in the gene encoding dyskerin. Sufferers have defects in highly regenerative tissues such as skin and bone marrow, chromosome instability and a predisposition to develop certain types of malignancy. Dyskerin is a putative pseudouridine synthase, and it has been suggested that DKC may be caused by a defect in ribosomal RNA processing. Here we show that dyskerin is associated not only with H/ACA small nucleolar RNAs, but also with human telomerase RNA, which contains an H/ACA RNA motif. Telomerase adds simple sequence repeats to chromosome ends using an internal region of its RNA as a template, and is required for the indefinite proliferation of primary human cells. We find that primary fibroblasts and lymphoblasts from DKC-affected males are not detectably deficient in conventional H/ACA small nucleolar RNA accumulation or function; however, DKC cells have a lower level of telomerase RNA, produce lower levels of telomerase activity and have shorter telomeres than matched normal cells. The pathology of DKC is consistent with compromised telomerase function leading to a defect in telomere maintenance, which may limit the proliferative capacity of human somatic cells in epithelia and blood.

Citing Articles

Diet, lifestyle and telomere length: using Copula Graphical Models on NHANES data.

Tedaldi A, Behrouzi P, Grootswagers P Aging (Albany NY). 2025; 17(2):329-356.

PMID: 39883078 PMC: 11892917. DOI: 10.18632/aging.206194.


A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches.

Iskandar M, Xiao Barbero M, Jaber M, Chen R, Gomez-Guevara R, Cruz E Cancers (Basel). 2025; 17(2).

PMID: 39858038 PMC: 11764024. DOI: 10.3390/cancers17020257.


Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives.

Jia S, Yu X, Deng N, Zheng C, Ju M, Wang F Clin Transl Med. 2025; 15(1):e70190.

PMID: 39834094 PMC: 11746961. DOI: 10.1002/ctm2.70190.


Different phenotypes with different endings-Telomere biology disorders and cancer predisposition with long telomeres.

Savage S, Bertuch A Br J Haematol. 2024; 206(1):69-73.

PMID: 39462986 PMC: 11739769. DOI: 10.1111/bjh.19851.


Connecting the Dots: Telomere Shortening and Rheumatic Diseases.

Han F, Riaz F, Pu J, Gao R, Yang L, Wang Y Biomolecules. 2024; 14(10).

PMID: 39456194 PMC: 11506250. DOI: 10.3390/biom14101261.